Similarly, in subjects with non-alcoholic steatohepatitis (NASH), hepatic PPARα expression declined with the development of NASH features and was negatively correlated with the severity of steatosis, hepatocyte ballooning or fibrosis [26]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.